US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Regentis Biomaterials Ltd.

2.16

+0.06002.86%

Pre-market: 2.03-0.1300-6.02%08:37 EDT

Volume:25.65K

Turnover:53.42K

Market Cap:15.20M

PE:-0.09

High:2.18

Open:2.15

Low:1.96

Close:2.10

52wk High:15.50

52wk Low:1.23

Shares:7.04M

Float Shares:4.84M

Volume Ratio:0.33

T/O Rate:0.53%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-24.1591

EPS(LYR):-24.1600

ROE:--

ROA:-107.53%

PB:3.20

PE(LYR):-0.09

Loading ...

Overview Company News Filings

Regentis Biomaterials (NYSE American: RGNT) Moves GelrinC Along Parallel US Clinical and European Commercial Tracks

Regentis Biomaterials Posts Investor Deck on GelrinC Off-the-Shelf Knee Cartilage Repair Hydrogel

Regentis Biomaterials (NYSE American: RGNT) Advances Regenerative Solution for Major Unmet Need in Cartilage Repair

Regentis Biomaterials (NYSE American: RGNT) Targets $3B Cartilage Repair Market with Cell-Free Gelrin C

Regentis Biomaterials (NYSE American: RGNT) Builds Commercial and Regulatory Momentum as GelrinC Advances Toward Key Milestones

Regentis Biomaterials (NYSE American: RGNT) Positioned to Benefit as Regenerative Medicine Reshapes the Growing $3B Cartilage Repair Market

Regentis Wins Japanese Patent Allowance for Gelrinc Solvent-free Manufacturing Process

Regentis Biomaterials Gets Approval for Cartilage Product Manufacturing Process From European Regulator

MT Newswires Live

Regentis receives European regulatory approval for new GelrinC manufacturing

Regentis Receives European Regulatory Approval for New Gelrinc Manufacturing Process

THOMSON REUTERS

Regentis Wins EU Approval for New Gelrinc Manufacturing Process

Regentis Biomaterials Shareholders Approve All Proposals at July 9 Adjourned AGM

Regentis Biomaterials Holds Annual Shareholder Meeting

Regentis Biomaterials Files Resale Registration for 3.8 Million Shares

MT Newswires Live

Regentis Biomaterials registers to sell 3.81M ordinary shares for holders

Core AI Names Arie Goor as CFO

MT Newswires Live

Core AI Holdings Names Arie Goor CFO Effective July 1, 2026

Regentis Biomaterials Adjourns Annual Shareholder Meeting to July 9 After no Quorum

Regentis Biomaterials Raises $6.5 Million in Private Placement to Advance GelrinC Program

Regentis Biomaterial Secures Deal to Raise $6.5 Million in Private Placement

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/RGNT/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RGNT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RGNT\",,,,,undefined,":{"symbol":"RGNT","market":"US","secType":"STK","nameCN":"Regentis Biomaterials Ltd.","latestPrice":2.16,"timestamp":1787601600000,"preClose":2.1,"halted":0,"volume":25651,"hourTrading":{"tag":"盘前","latestPrice":2.03,"preClose":2.16,"latestTime":"08:37 EDT","volume":673,"amount":1396.8898371999999,"timestamp":1787661467608,"change":-0.13,"changeRate":-0.060185,"amplitude":0.078704},"delay":0,"changeRate":0.028571428571428595,"floatShares":4842164,"shares":7036500,"eps":-24.159056,"marketStatus":"Pre-Mkt","change":0.06,"latestTime":"08-25 08:50:29 EDT","open":2.15,"high":2.18,"low":1.96,"amount":53415.1114243,"amplitude":0.104762,"askPrice":2.35,"askSize":100,"bidPrice":1.83,"bidSize":110,"shortable":3,"etf":0,"ttmEps":-24.159056,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787664600000},"marketStatusCode":1,"adr":0,"listingDate":1764824400000,"exchange":"AMEX","adjPreClose":2.16,"preHourTrading":{"tag":"盘前","latestPrice":2.03,"preClose":2.16,"latestTime":"08:37 EDT","volume":673,"amount":1396.8898371999999,"timestamp":1787661467608,"change":-0.13,"changeRate":-0.060185,"amplitude":0.078704},"postHourTrading":{"tag":"盘后","latestPrice":2.05,"preClose":2.16,"latestTime":"18:45 EDT","volume":330,"amount":681.0134,"timestamp":1787611534130,"change":-0.11,"changeRate":-0.050926,"amplitude":0.050926},"volumeRatio":0.33351969869563874},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RGNT\",,,,,undefined,":{"symbol":"RGNT","floatShares":4842164,"roa":"-107.53%","roe":"--","lyrEps":-24.159999,"volumeRatio":0.33351969869563874,"shares":7036500,"dividePrice":0,"high":2.18,"amplitude":0.104762,"preClose":2.1,"low":1.96,"week52Low":1.2316,"pbRate":"3.20","week52High":15.5,"institutionHeld":0,"latestPrice":2.16,"committee":0.047619,"eps":-24.159056,"divideRate":0,"volume":25651,"delay":0,"ttmEps":-24.159056,"open":2.15,"prevYearClose":6.74,"prevWeekClose":2.1,"prevMonthClose":1.74,"prevQuarterClose":3.53,"fiveDayClose":2.04,"twentyDayClose":2.06,"sixtyDayClose":1.98},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RGNT\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RGNT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RGNT\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RGNT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RGNT","date":"2026-08-21","current":-0.089407,"percent":0.778947,"low":-9.624274,"twenty":-6.021463,"median":-1.222019,"eighty":-0.777969,"high":11.294138,"avg":-2.351748,"sd":3.53883,"marketCap":10669518},"quantilePoints":[{"date":"2025-09-12","current":11.294138,"twenty":11.294138,"median":11.294138,"eighty":11.294138,"marketCap":54223158},{"date":"2025-09-17","current":11.294138,"twenty":11.294138,"median":11.294138,"eighty":11.294138,"marketCap":54223158},{"date":"2025-11-14","current":-9.624274,"twenty":-1.256909,"median":11.294138,"eighty":11.294138,"marketCap":54223158},{"date":"2025-11-20","current":-9.624274,"twenty":-9.624274,"median":11.294138,"eighty":11.294138,"marketCap":54223158},{"date":"2025-11-26","current":-9.624274,"twenty":-9.624274,"median":-9.624274,"eighty":11.294138,"marketCap":54223158},{"date":"2025-12-05","current":-6.894806,"twenty":-9.624274,"median":-7.354459,"eighty":11.294138,"marketCap":38845335},{"date":"2025-12-12","current":-6.563855,"twenty":-9.624274,"median":-6.89021,"eighty":11.294138,"marketCap":36980758},{"date":"2025-12-19","current":-5.880074,"twenty":-9.624274,"median":-6.600627,"eighty":11.294138,"marketCap":33128337},{"date":"2025-12-26","current":-6.113394,"twenty":-9.624274,"median":-6.527083,"eighty":1.180569,"marketCap":34442863},{"date":"2026-01-02","current":-6.196132,"twenty":-8.716348,"median":-6.3708,"eighty":-5.580196,"marketCap":34909007},{"date":"2026-01-09","current":-6.352414,"twenty":-7.170598,"median":-6.31555,"eighty":-5.626198,"marketCap":35789501},{"date":"2026-01-16","current":-7.078667,"twenty":-7.005123,"median":-6.260483,"eighty":-5.72734,"marketCap":39881210},{"date":"2026-01-23","current":-6.664979,"twenty":-6.894806,"median":-6.333844,"eighty":-5.846096,"marketCap":37550490},{"date":"2026-01-30","current":-5.635354,"twenty":-6.892967,"median":-6.278869,"eighty":-5.846096,"marketCap":31749587},{"date":"2026-02-06","current":-4.421869,"twenty":-6.856195,"median":-6.196132,"eighty":-5.571003,"marketCap":24912808},{"date":"2026-02-13","current":-4.026566,"twenty":-6.723814,"median":-6.113762,"eighty":-5.331983,"marketCap":22685675},{"date":"2026-02-20","current":-3.594492,"twenty":-6.664979,"median":-6.113394,"eighty":-4.421869,"marketCap":20251367},{"date":"2026-02-27","current":-1.495219,"twenty":-6.600627,"median":-6.113394,"eighty":-4.026566,"marketCap":20406749},{"date":"2026-03-06","current":-1.271316,"twenty":-6.563855,"median":-6.053639,"eighty":-3.612878,"marketCap":17350916},{"date":"2026-03-13","current":-1.282663,"twenty":-6.527083,"median":-5.880074,"eighty":-1.504175,"marketCap":17505779},{"date":"2026-03-20","current":-1.196479,"twenty":-6.527083,"median":-5.644593,"eighty":-1.282663,"marketCap":16329542},{"date":"2026-03-27","current":-1.153672,"twenty":-6.526991,"median":-5.56181,"eighty":-1.271316,"marketCap":15745309},{"date":"2026-04-02","current":-1.138492,"twenty":-6.505001,"median":-5.341176,"eighty":-1.230216,"marketCap":15538134},{"date":"2026-04-10","current":-1.159364,"twenty":-6.396541,"median":-4.971155,"eighty":-1.194415,"marketCap":15822999},{"date":"2026-04-17","current":-1.214391,"twenty":-6.356091,"median":-4.421869,"eighty":-1.179477,"marketCap":16574009},{"date":"2026-04-24","current":-1.168851,"twenty":-6.34506,"median":-4.136653,"eighty":-1.176433,"marketCap":15952484},{"date":"2026-05-01","current":-1.104337,"twenty":-6.335719,"median":-3.755371,"eighty":-1.159364,"marketCap":15071989},{"date":"2026-05-08","current":-0.865254,"twenty":-6.326637,"median":-3.645054,"eighty":-1.156707,"marketCap":11808981},{"date":"2026-05-15","current":-0.777969,"twenty":-6.302772,"median":-3.401437,"eighty":-1.138492,"marketCap":10617724},{"date":"2026-05-22","current":-0.815919,"twenty":-6.267838,"median":-1.499697,"eighty":-1.134697,"marketCap":11135662},{"date":"2026-05-29","current":-0.751404,"twenty":-6.243936,"median":-1.282663,"eighty":-1.110409,"marketCap":10255168},{"date":"2026-06-05","current":-0.652735,"twenty":-6.210841,"median":-1.277843,"eighty":-0.952538,"marketCap":8908530},{"date":"2026-06-12","current":-0.721045,"twenty":-6.196132,"median":-1.273213,"eighty":-0.865254,"marketCap":9840818},{"date":"2026-06-18","current":-1.802612,"twenty":-6.163331,"median":-1.275111,"eighty":-0.865254,"marketCap":24602045},{"date":"2026-06-26","current":-1.574913,"twenty":-6.113836,"median":-1.282663,"eighty":-0.878916,"marketCap":21494418},{"date":"2026-07-02","current":-1.734302,"twenty":-6.113394,"median":-1.282663,"eighty":-0.902444,"marketCap":23669757},{"date":"2026-07-10","current":-1.38137,"twenty":-6.113394,"median":-1.369985,"eighty":-0.917624,"marketCap":18852935},{"date":"2026-07-17","current":-0.842484,"twenty":-6.113394,"median":-1.339625,"eighty":-0.916106,"marketCap":11498219},{"date":"2026-07-24","current":-0.74002,"twenty":-6.113394,"median":-1.282663,"eighty":-0.865254,"marketCap":10099787},{"date":"2026-07-31","current":-0.683095,"twenty":-6.113394,"median":-1.280253,"eighty":-0.838689,"marketCap":9322880},{"date":"2026-08-07","current":-0.747609,"twenty":-6.102271,"median":-1.275111,"eighty":-0.81535,"marketCap":10203374},{"date":"2026-08-14","current":-0.721045,"twenty":-6.085815,"median":-1.256325,"eighty":-0.781764,"marketCap":9840818},{"date":"2026-08-21","current":-0.781764,"twenty":-6.021463,"median":-1.222019,"eighty":-0.777969,"marketCap":10669518}],"updateTime":1787642528134},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RGNT\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660393394","title":"Regentis Biomaterials (NYSE American: RGNT) Moves GelrinC Along Parallel US Clinical and European Commercial Tracks","url":"https://stock-news.laohu8.com/highlight/detail?id=2660393394","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660393394?lang=en_us&edition=fundamental","pubTime":"2026-08-18 00:00","pubTimestamp":1786982415,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, August 17th, 2026, FinanceWire Regentis has passed 50% enrollment in the pivotal Phase III SAGE study of GelrinC, wit...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/regentis-biomaterials-nyse-american-rgnt-moves-gelrinc-along-parallel-us-clinical-and-european-commercial-tracks?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/regentis-biomaterials-nyse-american-rgnt-moves-gelrinc-along-parallel-us-clinical-and-european-commercial-tracks?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RGNT","AFG","BK4139","BK4107","BK4117","EPV","NYSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658806972","title":"Regentis Biomaterials Posts Investor Deck on GelrinC Off-the-Shelf Knee Cartilage Repair Hydrogel","url":"https://stock-news.laohu8.com/highlight/detail?id=2658806972","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658806972?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:58","pubTimestamp":1786535890,"startTime":"0","endTime":"0","summary":"Regentis Biomaterials posts investor deck on GelrinC off-the-shelf knee cartilage repair hydrogelRegentis outlined GelrinC, an acellular PEG hydrogel implant positioned as an off-the-shelf option for ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDLCZk0s:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RGNT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656657305","title":"Regentis Biomaterials (NYSE American: RGNT) Advances Regenerative Solution for Major Unmet Need in Cartilage Repair","url":"https://stock-news.laohu8.com/highlight/detail?id=2656657305","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656657305?lang=en_us&edition=fundamental","pubTime":"2026-08-04 01:30","pubTimestamp":1785778234,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, August 3rd, 2026, FinanceWire Regentis Biomaterials (NYSE American: RGNT) was featured in a recent article ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/regentis-biomaterials-nyse-american-rgnt-advances-regenerative-solution-for-major-unmet-need-in-cartilage-repair?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/regentis-biomaterials-nyse-american-rgnt-advances-regenerative-solution-for-major-unmet-need-in-cartilage-repair?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","RGNT","BK4117","AFG","NYSE","BK4107"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655579807","title":"Regentis Biomaterials (NYSE American: RGNT) Targets $3B Cartilage Repair Market with Cell-Free Gelrin C","url":"https://stock-news.laohu8.com/highlight/detail?id=2655579807","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655579807?lang=en_us&edition=fundamental","pubTime":"2026-07-31 01:30","pubTimestamp":1785432617,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, July 30th, 2026, FinanceWire Regentis Biomaterials (NYSE American: RGNT) is positioning its Gelrin C hydrog...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/regentis-biomaterials-nyse-american-rgnt-targets-3b-cartilage-repair-market-with-cell-free-gelrin-c?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/regentis-biomaterials-nyse-american-rgnt-targets-3b-cartilage-repair-market-with-cell-free-gelrin-c?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NYSE","AFG","RGNT","BK4107","BK4117","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655976858","title":"Regentis Biomaterials (NYSE American: RGNT) Builds Commercial and Regulatory Momentum as GelrinC Advances Toward Key Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2655976858","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655976858?lang=en_us&edition=fundamental","pubTime":"2026-07-30 01:00","pubTimestamp":1785344416,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, July 29th, 2026, FinanceWire Regentis is advancing GelrinC through a pivotal stage of development, with key catalysts...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/regentis-biomaterials-nyse-american-rgnt-builds-commercial-and-regulatory-momentum-as-gelrinc-advances-toward-key-milestones?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/regentis-biomaterials-nyse-american-rgnt-builds-commercial-and-regulatory-momentum-as-gelrinc-advances-toward-key-milestones?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","RGNT","BK4117","AFG","NYSE","BK4107"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654342047","title":"Regentis Biomaterials (NYSE American: RGNT) Positioned to Benefit as Regenerative Medicine Reshapes the Growing $3B Cartilage Repair Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2654342047","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654342047?lang=en_us&edition=fundamental","pubTime":"2026-07-28 02:30","pubTimestamp":1785177013,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, July 27th, 2026, FinanceWire Regentis is targeting an estimated $3 billion U.S. cartilage repair market opportunity, ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/regentis-biomaterials-nyse-american-rgnt-positioned-to-benefit-as-regenerative-medicine-reshapes-the-growing-3b-cartilage-repair-market?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/regentis-biomaterials-nyse-american-rgnt-positioned-to-benefit-as-regenerative-medicine-reshapes-the-growing-3b-cartilage-repair-market?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4117","RGNT","NYSE","AFG","BK4107"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652215076","title":"Regentis Wins Japanese Patent Allowance for Gelrinc Solvent-free Manufacturing Process","url":"https://stock-news.laohu8.com/highlight/detail?id=2652215076","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652215076?lang=en_us&edition=fundamental","pubTime":"2026-07-20 21:02","pubTimestamp":1784552567,"startTime":"0","endTime":"0","summary":"Regentis wins Japanese patent allowance for GelrinC solvent-free manufacturing processRegentis Biomaterials received a Notice of Allowance from Japan for a patent covering an organic solvent-free Gelr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nNDL9vgqGZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RGNT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651466008","title":"Regentis Biomaterials Gets Approval for Cartilage Product Manufacturing Process From European Regulator","url":"https://stock-news.laohu8.com/highlight/detail?id=2651466008","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651466008?lang=en_us&edition=fundamental","pubTime":"2026-07-15 21:40","pubTimestamp":1784122835,"startTime":"0","endTime":"0","summary":"Regentis Biomaterials  has obtained approval from the European Notified Body to manufacture its knee cartilage repair product GelrinC using its next-generation solvent-free manufacturing process, the company said Wednesday.The manufacturing process increases production yield fivefold and improves efficiency and scalability, the company said.Regentis prepares to commercially launch the product in Europe, it said.Price: 2.59, Change: +0.09, Percent Change: +3.56","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","RGNT","EPV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651466774","title":"Regentis receives European regulatory approval for new GelrinC manufacturing","url":"https://stock-news.laohu8.com/highlight/detail?id=2651466774","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651466774?lang=en_us&edition=fundamental","pubTime":"2026-07-15 21:20","pubTimestamp":1784121647,"startTime":"0","endTime":"0","summary":"Regentis Biomaterials (RGNT) announced it has received approval from the European Notified Body to manufacture GelrinC using its next-generation so...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/regentis-receives-european-regulatory-approval-for-new-gelrinc-manufacturing-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/regentis-receives-european-regulatory-approval-for-new-gelrinc-manufacturing-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RGNT","BK4139","EPV","EES","RSBA","MRGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651296465","title":"Regentis Receives European Regulatory Approval for New Gelrinc Manufacturing Process","url":"https://stock-news.laohu8.com/highlight/detail?id=2651296465","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651296465?lang=en_us&edition=fundamental","pubTime":"2026-07-15 21:06","pubTimestamp":1784120766,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nFWN43H1BI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RGNT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651465630","title":"Regentis Wins EU Approval for New Gelrinc Manufacturing Process","url":"https://stock-news.laohu8.com/highlight/detail?id=2651465630","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651465630?lang=en_us&edition=fundamental","pubTime":"2026-07-15 21:00","pubTimestamp":1784120428,"startTime":"0","endTime":"0","summary":"Regentis wins EU approval for new GelrinC manufacturing processRegentis won European Notified Body clearance for a next-generation, solvent-free GelrinC manufacturing process ahead of its Europe launc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nNDL6BPjlt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RGNT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650961972","title":"Regentis Biomaterials Shareholders Approve All Proposals at July 9 Adjourned AGM","url":"https://stock-news.laohu8.com/highlight/detail?id=2650961972","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650961972?lang=en_us&edition=fundamental","pubTime":"2026-07-10 04:58","pubTimestamp":1783630704,"startTime":"0","endTime":"0","summary":"Regentis Biomaterials Ltd ( ($RGNT) ) has provided an announcement. On July 9, 2026, Regentis Biomaterials Ltd. held its adjourned Annual General M...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/regentis-biomaterials-shareholders-approve-all-proposals-at-july-9-adjourned-agm?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/regentis-biomaterials-shareholders-approve-all-proposals-at-july-9-adjourned-agm?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RGNT","BK4139","BK4195","BK4229","AGM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650974754","title":"Regentis Biomaterials Holds Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2650974754","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650974754?lang=en_us&edition=fundamental","pubTime":"2026-07-10 04:33","pubTimestamp":1783629201,"startTime":"0","endTime":"0","summary":"Regentis Biomaterials holds annual shareholder meetingRegentis Biomaterials held an adjourned annual general meeting of shareholders on July 9, 2026.Shareholders adopted all 14 proposals presented at ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260709:nNDLKZB8j:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RGNT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650421919","title":"Regentis Biomaterials Files Resale Registration for 3.8 Million Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2650421919","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650421919?lang=en_us&edition=fundamental","pubTime":"2026-07-09 05:53","pubTimestamp":1783547593,"startTime":"0","endTime":"0","summary":"Regentis Biomaterials  on Wednesday filed a registration statement covering the potential resale of up to 3.81 million ordinary shares issued or issuable in connection with a June private placement.The company said it will not receive proceeds from sales of the shares by the selling shareholders but may receive proceeds if the associated warrants are exercised for cash.Shares of Regentis were up 1.6% in after-hours trading.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RGNT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650916992","title":"Regentis Biomaterials registers to sell 3.81M ordinary shares for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2650916992","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650916992?lang=en_us&edition=fundamental","pubTime":"2026-07-09 04:35","pubTimestamp":1783542926,"startTime":"0","endTime":"0","summary":"This filing relates to the offer and sale from time to time by the selling stockholders of up to 3.81M ordinary shares. The company is not selling ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/regentis-biomaterials-registers-to-sell-3-81m-ordinary-shares-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/regentis-biomaterials-registers-to-sell-3-81m-ordinary-shares-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RGNT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649598041","title":"Core AI Names Arie Goor as CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2649598041","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649598041?lang=en_us&edition=fundamental","pubTime":"2026-07-07 20:55","pubTimestamp":1783428907,"startTime":"0","endTime":"0","summary":"Core AI (CHAI) has named Arie Goor as chief financial officer, effective July 1.Goor, 43, has more than 15 years of executive financial leadership experience, including as chief financial officer of Regentis Biomaterials (RGNT), the company said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CHAI","ARTY","BK4020","AIPO","VTHR","RGNT","AGIX","QTOC","BK4139","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649987198","title":"Core AI Holdings Names Arie Goor CFO Effective July 1, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2649987198","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649987198?lang=en_us&edition=fundamental","pubTime":"2026-07-07 20:20","pubTimestamp":1783426829,"startTime":"0","endTime":"0","summary":"Core AI Holdings names Arie Goor CFO effective July 1, 2026Core AI Holdings named Arie Goor as chief financial officer, effective July 1, 2026.Goor previously served as CFO of NYSE-listed Regentis Bio","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nNDLcdNf7p:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","BCDF","CHAI","IE00BN0W2T93.GBP","RGNT","LU0314104364.USD","SG9999014039.USD","BK4585","LU2210149790.SGD","BK4139","IE00BN0W2V16.EUR","BK4112","BK4588","IE00B64PRP62.GBP","SG9999014013.SGD","IE00B3QW5Z07.USD","IE00BKPKM429.USD","LU2095319765.USD","NDAQ","SG9999014005.SGD","BK4020","IE00BGHQF748.EUR","LU2210150020.SGD","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648521633","title":"Regentis Biomaterials Adjourns Annual Shareholder Meeting to July 9 After no Quorum","url":"https://stock-news.laohu8.com/highlight/detail?id=2648521633","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648521633?lang=en_us&edition=fundamental","pubTime":"2026-07-03 04:31","pubTimestamp":1783024289,"startTime":"0","endTime":"0","summary":"Regentis Biomaterials adjourns annual shareholder meeting to July 9 after no quorumRegentis Biomaterials adjourned its July 2, 2026 annual shareholder meeting for one week due to lack of quorum.The me","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nNDL95lj5M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGNT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644603037","title":"Regentis Biomaterials Raises $6.5 Million in Private Placement to Advance GelrinC Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2644603037","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644603037?lang=en_us&edition=fundamental","pubTime":"2026-06-19 08:22","pubTimestamp":1781828539,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Regentis Biomaterials Ltd ( ($RGNT) ). On June 17, 2026, Regentis Biomaterials Ltd. entered into definitive sec...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/regentis-biomaterials-raises-6-5-million-in-private-placement-to-advance-gelrinc-program?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/regentis-biomaterials-raises-6-5-million-in-private-placement-to-advance-gelrinc-program?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RGNT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644056177","title":"Regentis Biomaterial Secures Deal to Raise $6.5 Million in Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2644056177","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644056177?lang=en_us&edition=fundamental","pubTime":"2026-06-18 16:21","pubTimestamp":1781770907,"startTime":"0","endTime":"0","summary":"Regentis Biomaterials  has agreed to sell $6.5 million worth of shares and warrants in a private placement, the regenerative medicine company said late Wednesday.The company will issue about 1.9 million common shares at $3.50 each, along with an equal number of warrants to buy its shares at $4.20 apiece, to institutional and accredited investors, it said. Regentis may also issue, in lieu of ordinary shares, pre-funded warrants at $3.4999 each, exercisable at a price of $0.0001 per share.Net proceeds will be used to support clinical and regulatory activities, product development, operational support, market-entry activities, working capital and general corporate purposes, Regentis said.Closing is expected to occur on or about June 23, subject to closing conditions.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RGNT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":57,"code":"91000000","status":"200"}]}}